Sudubrilimab [CAS 2387417-06-1]

Sudubrilimab (HS636) is an Ig G1-kappa monoclonal antibody against PDL1. Sudubrilimab is fused at the C terminus of the heavy chain to a TGF-β1 receptor II ectodomain (TGFBR2-ECD), and which can sequester the PD-1/PD-L1 pathway and TGF-β bioactivity in the immunosuppressive tumor microenvironment[1].

[2387417-06-1]

[Sudubrilimab]

PD-1/PD-L1

99.27

10 mM in DMSO

Store at -80°C for 2 years

Dry Ice